NLPR3炎症小体在心肌纤维化中的作用的研究
The Role and Progress of NLPR3 Inflammatory in Myocardial Fibrosis
摘要: NLRP3炎症小体是一种多蛋白寡聚体复合物,通过产生IL-1和IL-18来激活炎症反应。该复合物在创伤早期有助于愈合,但在持续激活后会导致不可逆的心室重构以及心肌纤维化。本文针对NLRP3炎症复合体在多种疾病所致心肌纤维化中所起的作用,以及目前发现可能存在的一些信号机制进行了综述。
Abstract: NLRP3 inflammatory is a multiprotein oligomer complex that activates inflammation by producing IL-1 receptors and IL-18, which not only contributes to wound healing, but also leads to irreversible ventricular remodeling and myocardial fibrosis after continuous activation. This article reviews the factors that cause the initiation and activation of NLRP3 inflammatory complex, and how the activated inflammatory complex promotes the fibrosis process and other pathophysiological processes of cardiovascular disease.
文章引用:马腾驰, 王晨曦, 周静, 高峰. NLPR3炎症小体在心肌纤维化中的作用的研究[J]. 临床医学进展, 2022, 12(1): 172-176. https://doi.org/10.12677/ACM.2022.121027

参考文献

[1] Mariann, G., Johannes, W., Isbaal, R., et al. (2017) Myocardial Fibrosis: Biomedical Research from Bench to Bedside. European Journal of Heart Failure, 19, 177-191. [Google Scholar] [CrossRef] [PubMed]
[2] Tian, F.M., Jiang, T., Qi, X.W., et al. (2021) Role of Cytokines on the Progression of Liver Fibrosis in Mice Infected with Echinococcus multilocularis. Infection and Drug Resistance, 14, 5651-5660. [Google Scholar] [CrossRef
[3] Wang, Y.C., Liu, X.X., Shi, H., et al. (2020) NLRP3 Inflammasome, an Immune-Inflammatory Target in Pathogenesis and Treatment of Cardiovascular Diseases. Clinical and Translational Medicine, 10, 91-106. [Google Scholar] [CrossRef] [PubMed]
[4] 刘旦旦. 血浆NLRP3及其下游因子IL-1β、IL-18与2型糖尿病合并急性冠脉综合征的相关性[D]: [硕士学位论文]. 延安: 延安大学, 2019.
[5] 白津宇. NLRP3炎症小体与急性冠脉综合征合并2型糖尿病患者PCI术后再狭窄的相关性[D]: [硕士学位论文]. 延安: 延安大学, 2020.
[6] 黄帅, 白津宇, 周静, 等. NLRP3炎性小体与心血管疾病[J]. 国际心血管病杂志, 2020, 47(1): 32-36.
[7] Pinar, A.A., Scott, T.E., Huuskes, B.M., et al. (2020) Targeting the NLRP3 Inflammasome to Treat Cardiovascular Fibrosis. Pharmacology & Therapeutics, 209, Article ID: 107511. [Google Scholar] [CrossRef] [PubMed]
[8] Lénárt, N., Brough, D. and Dénes, Á. (2016) Inflammasomes Link Vascular Disease with Neuroinflammation and Brain Disorders. Journal of Cerebral Blood Flow & Metabolism, 36, 1668-1685. [Google Scholar] [CrossRef
[9] Prabhu, S.D. and Frangogiannis, N.G. (2016) The Biological Basis for Cardiac Repair after Myocardial Infarction: From Inflammation to Fibrosis. Circulation Research, 119, 91-112. [Google Scholar] [CrossRef
[10] Osuka, A., Hanschen, M., Stoecklein, V., et al. (2012) A Protective Role for Inflammasome Activation Following Injury. Shock, 37, 47-55. [Google Scholar] [CrossRef
[11] Fix, C., Bingham, K. and Carver, W. (2010) Effects of Interleukin-18 on Cardiac Fibroblast Function and Gene Expression. Cytokine, 53, 19-28. [Google Scholar] [CrossRef] [PubMed]
[12] Weinheimer-haus, E.M., Mirza, R.E. and Koh, T.J. (2015) Nod-Like Receptor Protein-3 Inflammasome Plays an Important Role during Early Stages of Wound Healing. PLoS ONE, 10, e0119106. [Google Scholar] [CrossRef] [PubMed]
[13] Westermeier, F., Navarro-Marquez, M., Lopez-Crisosto, C., et al. (2015) Defective Insulin Signaling and Mitochondrial Dynamics in Diabetic Cardiomyopathy. Biochimica et Biophysica Acta, 1853, 1113-1118. [Google Scholar] [CrossRef] [PubMed]
[14] Bracey, N.A., Duff, H.J. and Muruve, D.A. (2014) Hierarchical Regulation of Wound Healing by NOD-Like Receptors in Cardiovascular Disease. Antioxidants & Redox Signaling, 22, 1176-1187. [Google Scholar] [CrossRef] [PubMed]
[15] Bracey, N.A., Gershkovich, B., Chun, J., et al. (2014) Mitochondrial NLRP3 Protein Induces Reactive Oxygen Species to Promote Smad Protein Signaling and Fibrosis Independent from the Inflammasome. Journal of Biological Chemistry, 289, 19571-19584. [Google Scholar] [CrossRef
[16] Qi, J., Yu, X.-J., Shi, X.-L., et al. (2016) NF-κB Blockade in Hypothalamic Paraventricular Nucleus Inhibits High-Salt-Induced Hypertension through NLRP3 and Caspase-1. Cardiovascular Toxicology, 16, 345-354. [Google Scholar] [CrossRef] [PubMed]
[17] Yue, Y.Y., Meng, K., Pu, Y.J., et al. (2017) Transforming Growth Factor Beta (TGF-β) Mediates Cardiac Fibrosis and Induces Diabetic Cardiomyopathy. Diabetes Research and Clinical Practice, 133, 124-130. [Google Scholar] [CrossRef] [PubMed]
[18] Zhang, X.H., Fu, Y., Li, H., et al. (2018) H3 Relaxin Inhibits the Collagen Synthesis via ROS- and P2X7R-Mediated NLRP3 Inflammasome Activation in Cardiac Fibroblasts under High Glucose. Journal of Cellular and Molecular Medicine, 22, 1816-1825. [Google Scholar] [CrossRef] [PubMed]
[19] Zhang, X.T., Dai, J.Z., Li, L., et al. (2017) NLRP3 Inflammasome Expression and Signaling in Human Diabetic Wounds and in High Glucose Induced Macrophages. Journal of Diabetes Research, 2017, Article ID: 5281358. [Google Scholar] [CrossRef] [PubMed]
[20] Gan, W.Q., Ren, J.Y., Li, T.G., et al. (2017) The SGK1 Inhibitor EMD638683, Prevents Angiotensin II-Induced Cardiac Inflammation and Fibrosis by Blocking NLRP3 Inflammasome Activation. Biochimica et Biophysica Acta (BBA)—Molecular Basis of Disease, 1864, 1-10. [Google Scholar] [CrossRef] [PubMed]
[21] Kang, L.-L., Zhang, D.-M., Ma, C.-H., et al. (2016) Cinnamaldehyde and Allopurinol Reduce Fructose-Induced Cardiac Inflammation and Fibrosis by Attenuating CD36-Mediated TLR4/6-IRAK4/1 Signaling to Suppress NLRP3 Inflammasome Activation. Scientific Reports, 6, Article No. 27460. [Google Scholar] [CrossRef] [PubMed]
[22] Mezzasoma, L., Antognelli, C. and Talesa, V.-N. (2016) Atrial Natriuretic Peptide Down-Regulates LPS/ATP-Mediated IL-1β Release by Inhibiting NF-kB, NLRP3 Inflammasome and Caspase-1 Activation in THP-1 Cells. Immunologic Research, 64, 303-312. [Google Scholar] [CrossRef] [PubMed]